BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18583002)

  • 1. Warfarin and intracranial haemorrhage.
    Appelboam R; Thomas EO
    Blood Rev; 2009 Jan; 23(1):1-9. PubMed ID: 18583002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy reversal in intracerebral haemorrhage.
    Sweidan AJ; Singh NK; Conovaloff JL; Bower M; Groysman LI; Shafie M; Yu W
    Stroke Vasc Neurol; 2020; 5(1):29-33. PubMed ID: 32411405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin reversal.
    Hanley JP
    J Clin Pathol; 2004 Nov; 57(11):1132-9. PubMed ID: 15509671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage.
    Rowe AS; Turner RM
    Am J Health Syst Pharm; 2010 Mar; 67(5):361-5. PubMed ID: 20172985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.
    Aguilar MI; Hart RG; Kase CS; Freeman WD; Hoeben BJ; GarcĂ­a RC; Ansell JE; Mayer SA; Norrving B; Rosand J; Steiner T; Wijdicks EF; Yamaguchi T; Yasaka M
    Mayo Clin Proc; 2007 Jan; 82(1):82-92. PubMed ID: 17285789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage.
    Krittalak K; Sawanyawisuth K; Tiamkao S
    Intern Med J; 2011 Oct; 41(10):750-4. PubMed ID: 22435901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral hemorrhage in patients receiving oral anticoagulation therapy.
    da Silva IR; Provencio JJ
    J Intensive Care Med; 2015 Feb; 30(2):63-78. PubMed ID: 23753250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
    Aiyagari V; Testai FD
    Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIIa for warfarin-associated intracranial bleeding.
    Ilyas C; Beyer GM; Dutton RP; Scalea TM; Hess JR
    J Clin Anesth; 2008 Jun; 20(4):276-9. PubMed ID: 18617125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.
    Frumkin K
    Ann Emerg Med; 2013 Dec; 62(6):616-626.e8. PubMed ID: 23829955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When should you restart anticoagulation in patients who suffer an intracranial bleed who also have a prosthetic valve?
    Chandra D; Gupta A; Grover V; Kumar Gupta V
    Interact Cardiovasc Thorac Surg; 2013 Apr; 16(4):520-3. PubMed ID: 23287592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, management and outcomes of adults with major trauma taking pre-injury warfarin in a Western Australian population from 2000 to 2005: a population-based cohort study.
    Mountain D; Sistenich V; Jacobs IG
    Med J Aust; 2010 Aug; 193(4):202-6. PubMed ID: 20712539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.
    Brody DL; Aiyagari V; Shackleford AM; Diringer MN
    Neurocrit Care; 2005; 2(3):263-7. PubMed ID: 16159073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
    Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
    World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists.
    Becattini C; Franco L; Masotti L; Nitti C; Cattinelli S; Cappelli R; Manina G; Sbrojavacca R; Pomero F; Agnelli G
    Eur J Intern Med; 2016 Sep; 33():47-54. PubMed ID: 27289494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the use and timeliness of anticoagulation reversal for warfarin related intracranial haemorrhage.
    Hanger C; Geddes J; Wilkinson T; Lee M; Pearson S; Butler A; Badami K
    N Z Med J; 2016 Nov; 129(1445):35-49. PubMed ID: 27857237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies of anticoagulation reversal in life-threatening bleeds.
    Rolfe S; Papadopoulos S; Cabral KP
    J Pharm Pract; 2010 Jun; 23(3):217-25. PubMed ID: 21507817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to and management of the acute stroke patient with atrial fibrillation: a literature review.
    Marmagkiolis K; Nikolaidis IG; Politis T; Goldstein L
    J Hosp Med; 2008 Jul; 3(4):326-32. PubMed ID: 18698609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.